Introduction {#s0001}
============

Nanoparticle titanium dioxide (Nano-TiO~2~) is a common nanomaterial with a size less than 100 nm. Because of its photocatalytic properties, chemical resistance, and thermal stability, Nano-TiO~2~ has been widely used in medicine, wastewater treatment, coatings, sterilization, cosmetics, food additives, biomedical ceramics, etc. TiO~2~ is generally considered to be a low-toxic chemical, but TiO~2~ is classified by IARC as a group 2B, possible human carcinogen.[@cit0001] TiO~2~ nanoparticles could generate amounts of free radicals, which induced indirect genotoxicity mainly by DNA-adduct formation.[@cit0002] The rutile-based Nano-TiO~2~, as a result of photocatalysis, have been shown to produce reactive oxygen species (ROS), then causing DNA damage in vitro.[@cit0003],[@cit0004] Nano-TiO~2~ could exist in the air, and enter the body through the respiratory tract, and caused hyperplasia and inflammation in mice.[@cit0005] National Institute for Occupational Safety and Health (NIOSH) lists recommend airborne exposure limits of 0.3 mg/m^3^ for ultrafine TiO~2~ as time-weighted average concentrations in the workplace.[@cit0006] Furthermore, intratracheal instillation of Nano-TiO~2~ has been shown to translocate to organs such as the liver[@cit0007],[@cit0008] and induce renal fibrosis in mice,[@cit0009] but the toxicological mechanism in distant organs is still unclear.

Nano-TiO~2~ exposure by intranasal administration for 90 days could induce ROS accumulation, lead to oxidation of lipids, proteins, and DNA, then trigger brain injury in mice.[@cit0010] ROS possess the ability to damage the DNA nucleobases.[@cit0011] Shukla et al[@cit0012] found that Nano-TiO~2~ induced ROS and oxidative stress in human epidermal cells (A431), leading to DNA oxidative damage and micronuclei formation. Previous studies have reported that Fork head O (*FOXO*) factors are involved in oxidative stress responses,[@cit0013] which increases cellular antioxidant activity.[@cit0014],[@cit0015] Furthermore, *FOXO3a*, a member of the *FOXO* subfamily, could provide protection against ROS-induced damage[@cit0013] and protects alveolar epithelial cells from oxidative stress.[@cit0016] The *FOXO* subfamily of transcription factors has been implicated in diverse physiologic processes, including cell cycle arrest, cell death, stress resistance, and apoptosis.[@cit0017] With ROS-induced DNA damage, Forkheads could contribute secondarily to defense through regulating the expression of proteins involved in the repair process.[@cit0018] *FOXO3* has important downstream targets of the phosphatidylinositol 3-kinase (*PI3K*)-protein kinase B (*AKT*) pathway.[@cit0019] ROS triggers *PI3K* kinase activation, which subsequently regulates *AKT* activation, leading to cell survival, proliferation, protein synthesis, and transcription.[@cit0020],[@cit0021] In addition, the oxidative stress response is regulated in part by *FOXO* induction of *MnSOD*, catalase, and growth arrest and DNA damage α (*GADD45α*).[@cit0013],[@cit0014],[@cit0018] The function of GADD is to protect cells and ensure survival by inducing cell cycle arrest, DNA repair, and promoting apoptosis. Furthermore, decreased *GADD45α* expression is also considered a survival mechanism, which is essential for escape from programmed cell death.[@cit0022] Checkpoint kinase (*ChK2*) is involved in the ataxia telangiectasia mutation (*ATM*) signaling pathway, which is activated as a downstream effector associated with DNA damage under oxidative stress conditions.[@cit0023],[@cit0024] Many studies have shown that X-ray repair cross complementing gene 1(*XRCC1*) plays a key role in DNA damage caused by oxidative stress.[@cit0025],[@cit0026] Previous studies have found that *XRCC1* gene deletion exacerbates γ-ray-induced DNA damage and cell cycle arrest in liver cancer cells.[@cit0027] Therefore, it is hypothesized that the *PI3K/AKT/FOXO3a* signaling pathway was activated in lung, liver, and kidney when ROS increased after intratracheal instillation of Nano-TiO~2~. Then the DNA repair was triggered to defense of the DNA damages.

In this study, a Nano-TiO~2~ exposure rat model through tracheal perfusion was established to evaluate the effects of Nano-TiO~2~ on oxidative stress and DNA damage in the lung, liver, and kidney of rats. We found *FOXO3a* did trigger the DNA-repair mechanism after Nano-TiO~2~ exposure. Our results might provide a theoretical basis for the future research and find the potentially therapeutic target for DNA damages induced by Nano-TiO~2~.

Materials and Methods {#s0002}
=====================

Characterization of Nano-TiO~2~ {#s0002-s2001}
-------------------------------

The anatase-phase Titanium (IV) oxide (Nano-TiO~2~, 99.7% purity) was purchased from Sigma Chemical Co. (St. Louis, MO, USA). The size and morphology of Nano-TiO~2~ were evaluated by Tecnai G220 transmission electron microscope (TEM, FEI, USA) and Sirion 200 scanning electron microscope (SEM, FEI, Holland). Before SEM analysis, the nanoparticles were sputter-coated with gold and then dispersed in buffer and cast onto a carbon-coated copper grid sample holder followed by evaporation at room temperature. The specific surface area of the Nano-TiO~2~ particles was calculated using the Brunauer-Emmett-Teller (BET) adsorption isotherm.

The size and zeta potential of Nano-TiO~2~ were performed on Delsa^TM^ Nano particle analysis instrument (Beckman Coulter, CA, USA). Additionally, the materials were examined for endotoxin content using a Toxin Sensor^TM^ Chromogenic LAL Endotoxin Assay Kit (Genscript, USA). No endotoxins were detected in Nano-TiO~2~.

Animals and Treatment {#s0002-s2002}
---------------------

Forty-five male laboratory-bred *SD* rats weighing 200±20 g were purchased from the Experimental Animal Center of Hebei Medical University (Shijiazhuang, China). Before experiment, the animals were fed in the experimental room for 2--3 days to habituate them to the environment of the laboratory. An ambient temperature of 25±2°C, relative humidity of 50±2%, and photoperiod of 12 hours were maintained throughout the study. All animals were fed a diet and water ad libitum in stainless cages, and they received humane treatment in compliance with the Principles of Laboratory Animal Care formulated by the National Society for Medical Research. The present protocol was approved by the Committee of the Ethics Animal Experiments of Hebei Medical University (IACUC-Hebmu-20,160,048). The food was purchased from the Experimental Animal Center of Hebei Medical University.

The rats were randomly divided into three groups (15 rats/group): the control group, and two TiO~2~ treatment groups (0.2 and 1.0 g/kg body weight). The suspensions of Nano-TiO~2~ were sonicated for 20 minutes and administrated to rats via one intratracheal injection at a dose of 0.6 mL/200 g body weight, respectively.[@cit0028] Rats in the control group were instilled with 0.6 mL PBS per 200 g body-weight. Before injection, the rats were anesthetized by ether. Food and water were provided 2 hours later. On the 1st, 3rd, and 7th days after exposure, five rats were sacrificed in each dose group. After anesthetizing by pentobarbital sodium, rats were sacrificed. Lung, liver, and kidney were separated to further detect at days 1, 3, and 7 after instillation. After weighting the body and tissues, the coefficients of lung, liver, and kidney were calculated as the ratio of tissues (wet weight, mg) to body weight (g).

Titanium Burden Analysis {#s0002-s2003}
------------------------

About 0.1--0.3 g of lung, liver, and kidney tissue was digested and analyzed for titanium contents, respectively. Tissues were digested in nitric acid (ultrapure grade, Beijing Fine Chemical Ltd., Beijing, China) overnight. After adding 0.5 mL H~2~O~2~, the mixed solution was completely digested by a microwave digestion system (MDS, Sineo Microwave Chemistry Technology Co., Ltd., China). Then, the solution was heated at 120°C to remove the remaining nitric acid until it was colorless and clear. The remaining solutions were diluted to 3 mL with 2% nitric acid. Then, the concentration in digested samples was detected by inductively coupled plasma-mass spectrometry (ICP-MS, ELAN DRC-e, PerkinElmer Co., USA). Then 0.5 μg/L Rhodium was chosen as an internal standard element. Data were expressed as ppb (nanograms per gram fresh tissue, ng/g).

The deposited alveolar fraction was predicted using the "multiple path particle dosimetry (MPPD) model" version 2.11, which is based on the aerosol characteristics.[@cit0029] The initial baseline sets of MPPD inputs based on data from the ICRP report (ICRP 1994) are listed in [[Supplementary Table 1](https://www.dovepress.com/get_supplementary_file.php?f=254969.docx)]{.ul}. The maximum reported Nano-TiO~2~ concentration (0.3 mg/m^3^) was referred to as an input parameter for the MPPD model to estimate the retained dose in the rat lung.

Histopathology {#s0002-s2004}
--------------

The lung, liver, and kidney tissues were separated and fixed in 4% paraformaldehyde, embedded in paraffin, and sectioned into 5 μm-thick slices. The resulting slides were stained with hematoxylin and eosin (HE) for histological examination according to the standard techniques. After staining, the histopathological changes were observed by optical microscope (Olympus, Japan).

Oxidative Stress Detection {#s0002-s2005}
--------------------------

The activities of anti-oxidase glutathione peroxidase (*GSH-Px*) and superoxide dismutase (*SOD*), and the levels of the lipid peroxidation product malonaldehyde (*MDA*) in the lung, liver, and kidney of rats were determined according to the methods described in our previous study using commercial kits (Nanjing JianchengBioeng Inst., China).[@cit0030] The data is expressed as units of activity or nanomoles per milligram of protein.

The intracellular ROS was measured using 2ʹ,7ʹ-dichlorofluorescein diacetate (DCFH-DA) as a probe.[@cit0031] About 50 mg of lung, liver, and kidney tissue were cut into pieces on the ice, and then incubated with 0.25% trypsin for 30 minutes at 37°C. After adding 250 μL FBS in order to stop digestion, the suspension was filtered through a nylon filter to yield individual cells. The cell suspension was centrifuged at 800 r/min for 10 minutes, and the supernatant was discarded. Thereafter, 1 mL of PBS containing 1 μL DCFH-DA dye was added to each tube. All the tubes were incubated for 30 minutes at 37°C and then DCFH-DA was discarded. After washing three times with PBS, 1 mL of PBS was added to each tube and fluorescence intensity was measured in flow cytometry (BD Biosciences, San Jose, CA, USA) using software at excitation and emission wavelengths of 488 nm and 525 nm, respectively.

DNA Damage Detection {#s0002-s2006}
--------------------

DNA damages induced by Nano-TiO~2~ were detected by Comet assay. Then 100 mg lung, liver, and kidney samples from each group were cut into pieces on ice, and then incubated with 0.25% trypsin for 30 minutes at 37°C. After adding 250 μL FBS to stop digestion, the suspension was filtered at nylon filter to yield individual cells. Then, cells suspended in 0.5% low melting agarose were spread on the normal melting agarose-coated (1%) slides. After lysing at 4°C overnight, the slides were soaked in electrophoretic buffer solution for 30 minutes and electrophoresed for 25 minutes at 25 V (300 mA) at 4°C. The cells were stained with 10 mg/mL ethidium bromide. Two hundred randomly chosen cells were scored visually using a fluorescence microscope (Olympus, Japan) coupled with a 515--560 nm wavelength excitation filter and 590 nm wavelength emission filter. The olive tail moment (OTM) of each comet was calculated using CASP analyzed software.

Western Blot Analysis {#s0002-s2007}
---------------------

Tissue lysates were homogenized with modified RIPA buffer containing 1% phenylmethylsulfonyl fluoride (PMSF) using a high throughput tissue grinder (Scientz, Ningbo, China). Total protein extracts were determined by using a Pierce^®^BCA protein assay kit (Thermo Fisher Scientific, USA). An equal amount of lysate proteins was loaded onto 10 or 12% SDS-polyacrylamide gels and electrophoretically transferred to polyvinylidene fluoride (PVDF) membranes (Millipore, Danvers, MA) using a wet transfer system (Liuyi, Beijing, China). After blocking with 5% nonfat milk in Tris-buffered saline containing 0.05% Tween-20 (TBST) for 3 hours at room temperature, membranes were incubated with primary antibody overnight at 4°C: including anti-FOXO3a antibody (Cell Signaling Technologies, Danvers, MA, USA) at 1:1000, rabbit anti-GADD45α antibody (Proteintech, Wuhan, China) at 1:200, rabbit anti-AKT antibody (Proteintech) at 1:2000, rabbit anti-XRCC1 antibody (Bioworld, Nanjing, China) at 1:500, rabbit anti-ChK2 antibody (Proteintech) at 1:600, rabbit anti-PI3K antibody (Abcam, Cambridge, UK) at 1:5000, rabbit anti-phosphor-AKT antibody (Abcam) at 1:5000, rabbit anti-phosphor-FOXO3a antibody (AffinityBiosciences, USA) at 1:1000, and monoclonal rabbit anti-GAPDH antibody (Proteintech) was used at 1:20,000. GAPDH served as an internal standard for Western blot analysis. After washing three times with TBST, all membranes were incubated with a horseradish peroxidase-conjugated anti-rabbit IgG secondary antibody (Cell Signaling Technologies) for 1 hour at 37°C. After being washed three times with TBST, the antibody-bound proteins were detected using enhanced chemiluminescence (TIANGEN, Beijing, China). Analysis of the Western blot was performed using Chemiluminescent Imaging System (Tanon, China) and quantified by Gel-Pro Analyzer 3.0.

Statistical Analysis {#s0002-s2008}
--------------------

Results were expressed as mean ± SE and data were analyzed using one-way analysis of variance (ANOVA) with Dunnett's multiple comparison tests to determine significance. Homogeneity of variance between all groups was ascertained. In all cases, *P*-values \<0.05 were considered statistically significant.

Results {#s0003}
=======

Characterization of Nano-TiO~2~ {#s0003-s2001}
-------------------------------

SEM and TEM analysis clearly showed a three-dimensional nanostructure of Nano-TiO~2~, which consisted of globular shaped particles ([Figure 1A](#f0001){ref-type="fig"} and B). The size reported by SEM and TEM ranged from 10--25 nm. The larger particles showed many spherical protrusions on the surface, which indicates that they were formed by fusing many smaller particles during the spray drying process. The BET results showed that the surface area of the particles was about 50 m^2^/g, and the diameter of Nano-TiO~2~ in PBS was 392.7±99.4 nm. The zeta potential of Nano-TiO~2~ was −26.49 mV, which indicated that the Nano-TiO~2~ were scattered in PBS.Figure 1Characterization of Ti and the contents of Ti in organs. (**A** and **B**) Scanning electron microscopy and transmission electron microscopy images of Nano-TiO~2~. The powder was deposited on 200-mesh copper grids. The particle primary structure was 10--30 nm and globular. (**C**) On the 7th day after instillation, the contents of Ti in tissues of rats in the 0, 0.2, and 1 g/kg Nano-TiO~2~ treatment groups. N=5, \**P*\<0.05, in comparison to the control group. (**D**) The contents of Ti in tissues of rats after 1 g/kg Nano-TiO~2~ treatment for 1, 3, and 7 days. N=5, \**P*\<0.05, in comparison to the 1-day group.

Body Weight Coefficients of Liver, Kidney, and Lung {#s0003-s2002}
---------------------------------------------------

After treatment for 1, 3, and 7 days, rats were sacrificed and the body weight and tissues/organs weight were determined. The weight of rats is shown in [[Supplementary Figure 1](https://www.dovepress.com/get_supplementary_file.php?f=254969.docx)]{.ul}. No obvious differences were found in the body weight coefficient between the control and treatment groups ([[Supplementary Table 2](https://www.dovepress.com/get_supplementary_file.php?f=254969.docx)]{.ul}).

Titanium Burden After Nano-TiO~2~ Treatment {#s0003-s2003}
-------------------------------------------

We measured the content of Ti in tissues in different exposure groups after 7 days of exposure. The contents of titanium in tissues are shown in [Figure 1C](#f0001){ref-type="fig"}. After Nano-TiO~2~ post-treatment for 7 days, the titanium levels in liver and kidney were significantly increased in the 1 g/kg Nano-TiO~2~ group (*P*\<0.05), respectively, whereas no significantly changes in the 0.2 g/kg Nano-TiO~2~ group compared with the control.

In order to detect the time-response and the clearance in different tissues after Nano-TiO~2~ treatment, we measured contents of Ti in tissues of rats after 1 g/kg Nano-TiO~2~ treatment for 1, 3, and 7 days ([Figure 1D](#f0001){ref-type="fig"}). Compared with post-treatment for 1 day, the titanium levels in lung were significantly decreased in post-treatment for 3 and 7 days, respectively (*P*\<0.05). Moreover, the titanium levels in liver and kidney were significantly increased in post-treatment for 7 days compared with 1 day (*P*\<0.05). The titanium standard curve and response analysis of ICP-MS are shown in [[Supplementary Figure 2](https://www.dovepress.com/get_supplementary_file.php?f=254969.docx)]{.ul}.

For the MPPD model, a steady-state retention dose would take 26.74 days or 4.3 months to achieve for 0.2 g/kg (about 40 mg) or 1 g/kg (about 200 mg) based on inhalation of an aerosol concentration of 0.3 mg/m^3^ (Time-weighted average concentrations in workplace) for 8 hours/day, 5 days/week.

Histopathological Changes of Liver, Kidney, and Lung Tissue in Rats After Nano-TiO~2~ Exposure {#s0003-s2004}
----------------------------------------------------------------------------------------------

After Nano-TiO~2~ exposure, there appeared to be histopathologic changes in the liver, kidney, and lung of rats.

Lung: In the control group, we can observe the neat bronchial epithelium and regular lumen, intact alveolar ducts and alveolar sacs, and normal elastic fibers and reticular fibers of alveolar septa with the capillary network normal dyed ([Figure 2A1](#f0002){ref-type="fig"}). In the 0.2 g/kg group, inflammatory cell infiltration in the bronchus and irregular bronchial lumen could be found ([Figure 2A2](#f0002){ref-type="fig"}). In the 1 g/kg group, aggravating irregular bronchial lumen, thickening of the alveolar wall, and alveolar septal were observed ([Figure 2A3](#f0002){ref-type="fig"}).Figure 2Effects of Nano-TiO~2~ exposure on the histopathological changes in the lung, liver, and kidney at 7 days after treatment. (**A**) The representative images of lung tissue of rats stained with HE. (**B**) The representative images of liver tissue of rats stained with HE. (**C**) The representative images of kidney tissue of rats stained with HE. Scale bar represents 50 μm. The arrow in A~2~ indicated irregular luminal inflammatory cell infiltration; The arrow in A~3~indicated the alveolar wall thickening. The arrow in B~2~ indicated cell disorder. The arrow in B~3~ indicated the spotty necrosis. The arrow in C~2~ indicated the gap increases. The arrow in C~3~ indicated necrosis. 1: Control group, 2: 0.2 g/kg group, 3: 1 g/kg group.

Liver: In the control group, the hepatocytes were arranged regularly and neatly around the central vein. In the 0.2 g/kg group, the cells were disordered, and distal cells of the central vein were stained more darkly than in the control group ([Figure 2B1](#f0002){ref-type="fig"} and [B2](#f0002){ref-type="fig"}). In the 1 g/kg group, the vacuoles were observed in the cytoplasm and punctate necrosis appeared in the inflammatory cells ([Figure 2B3](#f0002){ref-type="fig"}).

Kidney: In the control group, the cells were arranged regularly, and the glomeruli and tubules were closely arranged. In the 0.2 g/kg group, the renal tubular gap increased compared with the control group ([Figure 2C1](#f0002){ref-type="fig"} and C2). In the 1 g/kg group, the renal tubular showed edema accompanied with partial necrosis ([Figure 2C3](#f0002){ref-type="fig"}).

Changes of Oxidative Stress Levels Induced by Nano-TiO~2~Rats {#s0003-s2005}
-------------------------------------------------------------

Lung: Compared with the control group, *SOD*, *GSH-Px* activities were significantly decreased (*P*\<0.05) and *MDA* content was significantly increased (*P*\<0.05) in a concentration dependent manner. Compared with that on day 1 after Nano-TiO~2~ exposure, *SOD* activity was significantly decreased in the 0.2 and 1.0 g/kg groups at 1, 3, and 7 days post-exposure (*P*\<0.05). There was no significant change in *GSH-Px* activity in each dose group at 3 days and 7 days post-exposure compared to 1 day. *MDA* content was significantly increased in the 0.2 g/kg group at 7 days post-exposure (*P*\<0.05), but no significant changes were found in the 1 g/kg group at 3 days and 7 days after Nano-TiO~2~ exposure compared to 1 day ([Figure 3A](#f0003){ref-type="fig"}--[C](#f0003){ref-type="fig"}).Figure 3The oxidative stress levels in the lung, liver, and kidney of rats after Nano-TiO~2~ treatment. (**A**--**C**) The SOD, GSH-Px activities, and MDA content in lung of rats. (**D**--**F**) The SOD, GSH-Px activities, and MDA content in liver of rats. (**G**--**I**) The SOD, GSH-Px activities, and MDA content in kidney of rats. (**J**--**L**) ROS levels induced by Nano-TiO2 in organs of rats. N=5, \**P*\<0.05, in comparison to the control group; ^\#^*P*\<0.05, in comparison to the 0.2 g/kg group.**Abbreviations:** SOD, superoxide dismutase; GSH-Px, glutathione peroxidase; MDA, malonaldehyde.

Liver: *SOD*, *GSH-Px* activities were significantly decreased (*P*\<0.05) and *MDA* content was significantly increased (*P*\<0.05) in a dose dependent manner compared with the control group. Compared with that on day 1 after Nano-TiO~2~ exposure, *SOD* activity was significantly increased (*P*\<0.05) in the 0.2 g/kg group at 3 days and 7 days after Nano-TiO~2~ exposure; *SOD* activity was significantly increased in the 1 g/kg group at 7 days after Nano-TiO~2~ exposure (*P*\<0.05); *GSH-Px* activity was significantly increased in each group at 3 days and 7 days after Nano-TiO~2~ exposure, (*P*\<0.05); *MDA* content was not significantly changed in each group at 3 days after Nano-TiO~2~ exposure compared to 1 day, whereas *MDA* content was significantly decreased in each group at 7 days after Nano-TiO~2~ exposure (*P*\<0.05) ([Figure 3D](#f0003){ref-type="fig"}--[F](#f0003){ref-type="fig"}).

Kidney: Compared with the control group, *SOD*, *GSH-Px* activities were significantly decreased (*P*\<0.05), *MDA* content was significantly increased (*P*\<0.05). Compared with that on day 1 after Nano-TiO~2~ exposure, *SOD* activity was significantly increased in the 0.2 g/kg and 1 g/kg groups at 3 days and 7 days after Nano-TiO~2~ exposure (*P*\<0.05); GSH-Px activity was significantly increased in each dose at 3 days and 7 days after Nano-TiO~2~ exposure (*P*\<0.05); *MDA* content showed no significant change in each dose at 3 days after Nano-TiO~2~ exposure compared to 1 day; *MDA* content was significantly decreased in the 0.2 g/kg and 1 g/kg groups at 7 days after Nano-TiO~2~ exposure (*P*\<0.05) ([Figure 3G](#f0003){ref-type="fig"}--[I](#f0003){ref-type="fig"}).

Nano-TiO~2~ exposure resulted ina significant increase in ROS, which was evident through increased fluorescence intensity in lung and liver compared to the control group ([Figure 3J](#f0003){ref-type="fig"} and [K](#f0003){ref-type="fig"}). A significant increase was noted in these groups in a dose dependent manner. In our study, although an increase of 10.39% and 19.08% at 0.2 and 1 g/kg, respectively, was noted at 7 days post-treatment in kidney, only the 1 g/kg group was statistically significant compared with the control group ([Figure 3L](#f0003){ref-type="fig"}).

DNA Damage Induced by Nano-TiO~2~ {#s0003-s2006}
---------------------------------

A significant induction (*P*\<0.05) in DNA damage was observed in the liver, kidney, and lung of rats exposed to Nano-TiO~2~ at 0.2 and 1 g/kg concentrations compared to control, as evidenced by the Comet assay parameters ie OTM and tail DNA (%). Compared with that on day 1 after Nano-TiO~2~ exposure, OTM and Tail DNA% in the lung ([Figure 4A](#f0004){ref-type="fig"} and [B](#f0004){ref-type="fig"}), kidney ([Figure 4C](#f0004){ref-type="fig"} and [D](#f0004){ref-type="fig"}), and liver ([Figure 4E](#f0004){ref-type="fig"} and [F](#f0004){ref-type="fig"}) tissue of all dose group showed no significant differences at 3 days and 7 days post-exposure. There was an apparent dose-response relationship and representative pictures of the lung are shown in [Figure 4G1](#f0004){ref-type="fig"}--[G3](#f0004){ref-type="fig"}.Figure 4The DNA damage levels in the lung, liver, and kidney of rats after Nano-TiO~2~ treatment. (**A** and **B**): The OTM value and Tail DNA% value changed in the lung after Nano-TiO~2~ treatment at different times. (**C** and **D**) The OTM value and Tail DNA% value changed in the liver after Nano-TiO~2~ treatment at different times. (**E** and **F**) The OTM value and Tail DNA% value changed in the lung after Nano-TiO~2~ treatment at different times. (**G**) Representative images of DNA damage in the lung of rats after Nano-TiO~2~ treatment for 7 days (400x). (G~1~: control group; G~2~: 0.2 g/kg Nano-TiO~2~ treatment group; G~3~: 1 g/kg Nano-TiO~2~ treatment group). The result was the average of at least three independent experiments. N=5, \**P*\<0.05: day 1 in comparison to the control group; ^\#^*P*\<0.05: day 3 in comparison to the control group; ^○^*P*\<0.05: day 7 in comparison to the control group.

Activation of PI3K-AKT-FOXO3a Signal Pathway in Tissues of Rats After Nano-TiO~2~ Treatment {#s0003-s2007}
-------------------------------------------------------------------------------------------

The *PI3K*/*AKT* pathway is well known to be involved in endothelial cell proliferation and cell survival and also plays an important role in DNA repair. To investigate whether Nano-TiO~2~ could induce the activation of the *PI3K*/*AKT*/*FOXO3a* signaling pathway, we examined the amount of *PI3K*, *AKT*, *phosphorylated AKT*, *FOXO3a*, and phosphorylated *FOXO3a* in the lung, liver, and kidney after single treatment with Nano-TiO~2~ for 7 days and the control group. Nano-TiO~2~ treatment had no effect on *AKT* protein expression, but it increased the expression of the *PI3K*, phosphorylated *AKT*, and phosphorylated *FOXO3a* after Nano-TiO~2~ treatment ([Figure 5](#f0005){ref-type="fig"}). As shown in [Figure 5](#f0005){ref-type="fig"}, the ratios of *p-AKT*/*AKT* and *p-FOXO3a*/*FOXO3a* in the lung ([Figure 5C](#f0005){ref-type="fig"} and [D](#f0004){ref-type="fig"}), liver ([Figure 5G](#f0005){ref-type="fig"} and [H](#f0005){ref-type="fig"}), and kidney ([Figure 5K](#f0005){ref-type="fig"} and [L](#f0004){ref-type="fig"}) were significantly increased in a dose-dependent manner after exposure to Nano-TiO~2~. These results suggested that DNA damage induced by Nano-TiO~2~ might relate with the activation of the *PI3K-AKT-FOXO3a* signaling pathway.Figure 5Activation of the PI3K-AKT-FOXO3a signal pathway in the lung, liver, and kidney of rats after Nano-TiO~2~ treatment for 7 days. (**A**) The represented protein bands of PI3K, AKT, FOXO3a, p-AKT, and p-FOXO3a in the lung. (**B**--**D**) The fold changes of PI3K, p-AKT/AKT, and p-FOXO3a/FOXO3a levels in the lung. (**E**--**H**) The represented protein bands and fold changes of PI3K, AKT, FOXO3a, p-AKT, and p-FOXO3a in the liver. (**I**--**L**) The represented protein bands and fold changes of PI3K, AKT, FOXO3a, p-AKT, and p-FOXO3a in the kidney. N=5, \**P*\<0.05, in comparison to the control group. ^\#^*P*\<0.05, in comparison to the 0.2 g/kg group.**Abbreviations:** PI3K, phosphatidyl inositol 3-kinase; AKT, protein kinase B; FOXO3a, the Fork head box class O 3a.

Changes of DNA Repair Signal-Related Proteins in Tissues of Rats Exposed to Nano-TiO~2~ {#s0003-s2008}
---------------------------------------------------------------------------------------

*GADD45α* as a downstream signal molecule of *FOXO3a* can reflect DNA damage repair. Further DNA repair pathways were confirmed through Western blot analysis of various DNA damage repair markers such as *XRCC1* and *ChK2* ([Figure 6A](#f0006){ref-type="fig"}). Significant increases of *XRCC1* ([Figure 6B](#f0006){ref-type="fig"}), *ChK2* ([Figure 6C](#f0006){ref-type="fig"}), and *GADD45α* ([Figure 6D](#f0006){ref-type="fig"}) expression were found in lung of rats in a dose dependent manner after Nano-TiO~2~ treatment.Figure 6Changes of DNA repair proteins in the lung, liver, and kidney of rats exposed to Nano-TiO~2~ for 7 days. (**A**--**D**) The represented protein bands and fold changes of XRCC1, ChK2, and GADD45α in the lung. (**E**--**H**) The represented protein bands and fold changes of XRCC1, ChK2, and GADD45α in the liver. (**I**--**L**) The represented protein bands and fold changes of XRCC1, ChK2, and GADD45α in the kidney. N=5, \**P*\<0.05, in comparison to the control group. ^\#^*P*\<0.05, in comparison to the 0.2 g/kg group.**Abbreviations:** XRCC1, x-ray repair cross complementing gene 1; ChK2, checkpoint kinase 2; GADD45α, growth arrest and DNA damage α.

In the liver and kidney of rats, Nano-TiO~2~ exposure resulted in dose-dependent increases of *XRCC1*, *ChK2*, and *GADD45α* expression (*P*\<0.05) ([Figure 6E](#f0006){ref-type="fig"}--[L](#f0006){ref-type="fig"}).

Discussion {#s0004}
==========

In recent years, with the rapid development of nanotechnology, Nano-TiO~2~ has been widely used in coatings, paints, and other fields.[@cit0032] The National Institute for Occupational Safety and Health (NIOSH) lists Nano-TiO~2~ as a potential occupational carcinogen[@cit0006] and recommends airborne exposure limits of 2.4 mg/m^3^ for fine TiO~2~ and 0.3 mg/m^3^ for ultrafine (including engineered nanoscale) TiO~2~ as time-weighted average concentrations. Although the most reliable studies for exploring the pulmonary toxicity of nanomaterials are inhalation studies, intratracheal instillation studies are useful for examining the dose-dependent manner of nanomaterials.[@cit0033],[@cit0037]

The pattern of pulmonary inflammation ranking of nanomaterials is the same in inhalation studies and intratracheal instillation studies. Therefore, intratracheal instillation studies might be useful for ranking the harmful effects of nanomaterials.[@cit0034],[@cit0037],[@cit0038]

In the present study, we observed Ti in the liver and kidney in the 0.2 g/kg and 1 g/kg groups after intratracheal injection of Nano-TiO~2~, in which the accumulated deposition in the lung was equal to about 26.74 days or 4.3 months exposure in human (8 hours per day, 0.3 mg/m^3^, limitation by NIOSH) for Nano-TiO~2~ calculated by the MPPD model.[@cit0029],[@cit0039]

It was shown that ultrafine TiO~2~ particles could induce oxidative bronchial epithelial cell DNA damage.[@cit0040] Besides, TiO~2~ could cause DNA double-strand breaks via the generation of a continued increased level of ROS.[@cit0041] Proven pulmonary carcinogen could induce greater levels of ROS, leading to enhanced DNA damage and apoptosis. Amounts of evidence implicate ROS-induced DNA double-strand breaks as a signal, which activates transcription factors and leads to cell proliferation and carcinogenesis. The markers of oxidative stress in exhaled breath condensate samples were significantly higher in TiO~2~ production workers than in unexposed controls.[@cit0042] Furthermore, several lipid oxidative markers (including malondialdehyde) were elevated in TiO~2~ production workers relative to the controls.[@cit0001] Zhao et al[@cit0043] found oxidative stress markers (*SOD* and *MDA*), and inflammation markers (*IL-8*, *IL-6*, *IL-1β*, *TNF-α*, and *IL-10*) were associated with occupational exposure to Nano-TiO~2~. The toxicity of TiO~2~ nanoparticles could mainly depend on the structural characteristics.[@cit0044] Zhang et al[@cit0045] detected the cytotoxicity of different-sized TiO~2~ nanoparticles. They found that the 25-nm anatase-phase TiO~2~ induced stronger cytotoxicity and oxidative stress than those of 5- and 100- nm anatase-phase TiO~2~. The 5- and 100-nm anatase-phase TiO~2~ had similar toxicity. Besides, anatase particles caused higher toxicity than rutile particles. Anatase-phase TiO~2~ induce observable DNA stress and membrane damage.[@cit0046] Xiong et al[@cit0047] found the correlation between cytotoxicity of TiO~2~ nanoparticles and particle size. This is because smaller particles have larger specific surface area, which could absorb more biomolecules in the environment. The biological effects might associate with particle size, dry particle size, and surface area.[@cit0048]

Nano-TiO~2~ usually enters the body through the skin, respiration, or digestion. TiO~2~ suspension (5 g/kg body weight) was given to mice by a syringe via gastrointestinal tract for 2 weeks, and TiO~2~ could accumulate in the liver, spleen, kidney, and lung tissues.[@cit0049] Shinohara et al[@cit0050] reported 94%, 2.0%, 0.17%, and 0.023% Ti were observed in the liver, spleen, lung, and kidney at 6 hours after intratracheal injection of Nano-TiO~2~, respectively. After 2, 10, and 50 mg/m^3^ Nano-TiO~2~ inhalation for 6 hours/day and continuing for 5 days, Nano-TiO~2~ burdens in the lung were 118.4, 544.9, and 1635 μg, respectively. After 16-day recovery, Nano-TiO~2~ burdens decreased to 25, 144.5, and 295 μg in the lung, respectively.[@cit0051] Oberdörster et al[@cit0052] reported that retention half times were 117 days for those exposed to fine particles (250 nm TiO~2~), and 541 days for those exposed to ultrafine particles (20 nm TiO~2~). In the 1 g/kg group of the present study, there was a significant increase in titanium content in the liver and kidney tissues with time, which might be related to the longer half-life period of TiO~2~. Our data suggested that slowly clearance of Ti and low particle translocation might partly explain that titanium was higher in lung tissue compared with liver and kidney. Accumulation of titanium in lung tissue caused continuous damage to the respiratory system. The titanium content in liver tissue increased, resulting in decreased liver detoxification ability. The accumulation of titanium in the kidney causes kidney damage and reduces excretion.

Studies have shown that Nano-TiO~2~ can cause significant inflammatory damage and pathological changes in the lungs and extra pulmonary organs. Nano-TiO~2~ inhalation resulted in alveolar macrophage and neutrophil infiltration in rats.[@cit0051] On the 7th day after 5 nm TiO~2~ particles treatment via tracheal instillation, proliferation of macrophages was observed, as well as massive particulate deposition in gaps and the alveolar cavity of lung tissue in rats were found.[@cit0053] Similarly, in the present study, we found inflammatory cells infiltrated in the lungs. Bronchus and the alveolar wall became thickened. Tracheal perfusion of Nano-TiO~2~ for 4 weeks showed pathological damage to lung tissue,[@cit0054] and renal fibrosis.[@cit0009] However, in our study, we did not find renal fibrosis, which might be due to the acute exposure by one-time intratracheal instillation. In addition, we found the disordered arrangement of liver cells and inflammatory cells in livers. Similarly, Nano-TiO~2~ caused serious damage to the liver, and the indicators of liver function, such as alkaline phosphatase, alanine aminotransferase, leucine acid peptide, pseudocholinesterase, total protein, and albumin level, were enhanced significantly.[@cit0032],[@cit0055]

Our previous studies[@cit0030] showed that Nano-TiO~2~ could induce liver and kidney function damage in mice, which is closely related to the increase of ROS and the decline of antioxidant capacity. The increase of ROS might lead to an imbalance in the oxidative metabolism of the cell and cause tissue damage.[@cit0056],[@cit0058] In the present study, we found that after treatment with Nano-TiO~2~, there was a dose-dependent ROS increase in the lung and liver. In kidney, only the 1 g/kg group was statistically significant compared with the control. This may be due to the fact that most of the ROS had been eliminated by the cellular antioxidant system,[@cit0059] or low (0.2 g/kg) concentrations of Nano-TiO~2~ were not sufficient to cause mitochondrial damage, thereby failing to increase the ROS. After being ingested by cells, the nanoparticles enter the mitochondria,[@cit0060] interfering with the antioxidant defense mechanism of the cells or increasing the content of reactive oxygen species inside the mitochondria, but low levels of oxidative stress induce protective responses. Studies have shown that the reduction of antioxidant enzymes (such as glutathione peroxidase, superoxide dismutase, catalase) is related to oxidative damage in the body.[@cit0061]

After Nano-TiO~2~ treatment by subcutaneous injection, the *MDA* content in the liver of mice increased, whereas *SOD* and *GSH-Px* activity decreased.[@cit0062] The results of our study showed that the levels of *MDA* in liver, kidney, and lung tissues of rats were significantly increased, and the activities of *SOD* and *GSH-Px* were significantly decreased. On the 3th day and 7th day in the 0.2 g/kg and 1 g/kg groups, the activity of *SOD*, *GSH-Px*, and *MDA* in rats recovered partially, suggesting that the antioxidant system of the body played its own protective role. Thus, the observed Nano-TiO~2~-induced genotoxicity in the present study could be attributed to the accumulation of ROS generated by Nano-TiO~2~, as indicated by the significant elevations of *MDA* levels that depleted cellular *GSH* and resisted the defensive effects of cellular antioxidant enzymes including *SOD* and *GPx* in a dose-dependent manner leading to oxidative stress that causes lipid peroxidation and can damage DNA ([Figure 7](#f0007){ref-type="fig"}).Figure 7A proposed action model for the PI3K/AKT/FoxO3a pathway via ROS regulating DNA damage in the lung, liver, and kidney induced by Nano-TiO~2~ intratracheal administration.

It has been documented that Nano-TiO~2~ induced oxidative stress[@cit0063],[@cit0065] and DNA damage in mouse brain, liver, and bone marrow cells[@cit0066] and human kidney embryo cells.[@cit0067] The oxidative stress can induce oxidative DNA lesions such as DNA strand breaks.[@cit0068],[@cit0069] In this study, the contents of OTM and Tail DNA in the liver, kidney, and lung tissues of the rats in each dose group were significantly increased compared with the control group, indicating that Nano-TiO~2~ damaged the DNA, which was consistent with the above results. There was no difference of the OTM and Tail DNA between the 1st, 3rd, and 7th days, suggesting that the damage induced by Nano-TiO~2~ could be irreversible, which might have contributed to the dysfunction of repair ability.

When cells are under oxidative stress, the expression of *FOXO3a* was significantly increased, and further activated downstream signaling pathways for anti-oxidation and DNA repair functions.[@cit0070] *FOXO3a* resist oxidative stress through phosphorylation at T32, S253, and S315, which is activated by the *PI3K*/*AKT* pathway.[@cit0071] By catalyzing the phosphorylation of *FOXO3a*, *AKT* blocks *FOXO3a*-dependent transcription primarily by promoting the exclusion of *FOXO3a* from the nucleus, rendering the transcription factor unable to activate its target gene.[@cit0071] Previous studies suggested that ROS could activate the *PI3K*/*AKT* pathway,[@cit0020],[@cit0072],[@cit0073] leading to cell proliferation, translocation, and activation of serine/threonine kinases.[@cit0074],[@cit0075] Our results showthat the *PI3K* and *p-AKT* expression increased whereas the ratio of *p-FOXO3a*/*FOXO3a* decreased after Nano-TiO~2~ tracheal instillation in a dose-dependent manner. These data suggested that Nano-TiO~2~ could inhibit the activity of *FOXO3a* protein by activating the *PI3K*/*AKT* signaling pathway.

*FOXO* can regulate DNA repair by activating downstream *GADD45α* and forms the *FOXO3a*/*GADD45α* complex, which further initiates the process of downstream DNA damage repair to protect damaged cells.[@cit0018] *GADD45α* is a member of the *GADD45* gene family and can be rapidly induced by a variety of injury factors, playing an important role in the cellular response to stress at the G~2~-M checkpoint and maintaining genomic stability. Low doses of Nano-TiO~2~ up-regulated the expression of *GADD45α* in HepG2 cells.[@cit0076] *GADD45α* was increased in mice after oxidative stress,[@cit0077],[@cit0078] and DNA damage repair was abnormal in GADD45α knockout mice.[@cit0079] Our results indicated that the expression of *GADD45α* increased after Nano-TiO~2~ exposure, suggesting that Nano-TiO~2~ induced the expression of *GADD45α* in the lung, liver, and kidney, thereby promoting the DNA damage repair function. The formation of DNA strand breaks in turn activates a number of downstream targets, including histone H2AX, as well as the cellular check-point kinase *Chk2*.[@cit0080],[@cit0081] DNA damage consequently activated the *ATM--H2AX*/*Chk2--p53* pathway.[@cit0082] Nano-TiO~2~ can activate the human fibroblast DNA damage response to the *ATM-ChK2* pathway, thereby promoting *ChK2* expression.[@cit0083] The cell cycle monitoring point regulatory gene *ChK2* participated in the repair of DNA damage through the regulation of *XRCC1*.[@cit0084] *XRCC1* is a key gene in the base excision repair (*BER*) pathway and is highly reactive to a variety of DNA damaging agents, including oxidants, alkylating agents, radiation, etc. Reduced *XRCC1* function or *XRCC1* deficiency might exacerbate genomic instability and increased the risk of asbestos-related malignancy.[@cit0085] Our previous study found that *XRCC1* deficiency sensitizes HepG2 cells to cisplatin, leading to cell cycle disorder and decreased DNA repair capacity.[@cit0086] In the present study, the expression of *ChK2* and *XRCC1* in the lung, liver, and kidney increased in dose-dependent manners after intratracheal instillation of Nano-TiO~2~, suggesting that Nano-TiO~2~ could induce DNA damage by *ChK2* related cell-cycle arrest.

Conclusion {#s0005}
==========

Ti could distribute in main tissues of rats after intratracheal instillation of Nano-TiO~2~. Nano-TiO~2~ could produce oxidative stress in the lung, liver, and kidney, and then caused DNA damage, which could not recover within 7 days. Nano-TiO~2~ activated the *PI3K/AKT/FOXO3a* pathway and increased the expression of *GADD45α*, *ChK2*, and *XRCC1* in the lung, liver, and kidney of rats responding to DNA damage. This study might help to deepen the understanding of the regulation mechanism of DNA damage caused by Nano-TiO~2~.
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